Centaurus Financial Inc. Purchases 8,881 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Centaurus Financial Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 164.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 14,272 shares of the healthcare conglomerate's stock after purchasing an additional 8,881 shares during the quarter. Centaurus Financial Inc.'s holdings in UnitedHealth Group were worth $7,220,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction dated Friday, May 16th. The shares were bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock valued at $31,607,768 in the last ninety days. 0.33% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Truist Financial restated a "buy" rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. TD Securities restated a "hold" rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. JPMorgan Chase & Co. lowered their price objective on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. Finally, Barclays decreased their price target on UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $441.87.

UnitedHealth Group Trading Up 0.8%

UNH traded up $2.49 during midday trading on Wednesday, hitting $297.49. 15,953,133 shares of the company were exchanged, compared to its average volume of 6,708,326. The firm has a market capitalization of $269.87 billion, a P/E ratio of 19.19, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm's 50 day moving average price is $439.50 and its 200-day moving average price is $498.65. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the firm posted $6.91 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.